Erratum: Adjuvant radiotherapy in stage IV diff use large cell lymphoma improves outcome (Leukemia and Lymphoma (2004) 45:7 (1385-1389) DOI: 10.1080/10428190410001667712);Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improve outcome

Leukemia and Lymphoma

Volumn 45, Issue 7, 2004, Pages 1385-1389

  Avilés, Agustin ^a   Fernández, Raúl ^a   Pérez, Felipe ^a   Nambo, M Jesús ^a   Neri, Natividad ^a   Talavera, Alejandra ^a   Castañeda, Claudia ^a   González, Martha ^a   Cleto, Sergio ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Diffuse large cell lymphoma; Malignant lymphoma; Prognostic factors; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; PREDNISOLONE; VINCRISTINE;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CHRONIC DIARRHEA; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION FIELD; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME; XEROSTOMIA;

EID: 2542555752     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.808008     Document Type: Erratum

References (20)

1. Nicolaides, C., Fountzilai, G., Zoumbos, N., et al. (1998) "Diffuse large cell lymphoma. Identification of prognostic factors and validation of the International non-Hodgkin's lymphoma Prognostic Index", Oncology, 55, 405-415.
2. Cosset, J.M., Ozanne, F., Henry-Amar, M., et al. (1985) "An alternative chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies", Radiother. Oncol., 3, 133-138.
3. Fuller, L.M., Krasin, M.J., Velasquez, W.S., et al. (1995) "Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation", Int. J. Radiat. Oncol. Biol. Phys., 31, 3-11.
4. Schlembach, P., Wilder, R.B., Tucker, S.L., et al. (2000) "Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV intermediate grade and large-cell immunoblastic lymphoma", Int. J. Radiat. Oncol. Biol. Phys., 48, 1107-1110.
5. Wilder, R.B., Rodriguez, M.A., Chuc, H.S., et al. (2001) "Bulky disease is and adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, vincristine, doxorubicin, and prednisone, with or without radiotherapy for aggressive lymphoma", Cancer, 91, 2440-2446.
6. Ferreri, A.J.M., Dell'Oro, S., Reni, M., et al. (2000) "Consolidation radiotherapy to bulky or semibulky lesion in the management of stage III-IV diffuse large cell lymphoma", Oncology, 58, 219-226.
7. Oguchi, M., Ikeda, H., Isobe, K., et al. (2000) "Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma. A survey of the Japan Lymphoma Radiation Therapy Group", Int. J. Radiat. Oncol. Biol. Phys., 48, 161-168.
8. Mirza, M.R., Brincker, H., Spetch L., et al. (1992) "The integration of radiotherapy into the primary treatment of non-Hodgkin's lymphoma", Crit. Rev. Oncol. Hematol., 7, 217-229.
9. Wilder, R.B., Tucker, S.L., Ha, C.S., et al. (2001) "Dose-response analysis for radiotherapy delivered to patients with intermediate grade and large-cell immunoblastic lymphoma that have completally response to CHOP-based induction chemotherapy", Int. J. Radiat. Oncol. Biol. Phys., 49, 17-22.
10. Avilés, A., Delgado, S., Nambo, M.J., et al. (1994) "Adjuvant radiotherapy to site of previous bulky disease in patients stage IV diffuse large cell lymphoma", Int. J. Radiat. Oncol. Biol. Phys., 30, 799-804.
11. Avilés, A., Guzmán, R., Delgado, S., et al. (1996) "Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve prognosis in aggressive malignant lymphoma", Am. J. Hematol., 52, 275-280.
12. Avilés, A., Calva, A., Díaz-Maqueo, J.C., Talavera, A., García, E.L. (1997) "Dose escalation of epirubicin in the CEOP-Bleo regimen. A controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma", Leuk. Lymph., 25, 319-325.
13. Basaran, M., Baubeck, E.S., Salar, R., et al. (2001) "Treatment of aggressive non-Hodgkin's lymphoma with dose intensified epirubicin in combination with cyclophosphamide, vincristine and prednisone", Am. J. Clin. Oncol., 24, 570-572.
14. Nair, R., Rammaknishnan, G., Nair, N.N.A., et al. (1998) "A randomized comparison of the efficacy of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma", Cancer, 82, 2282-2288.
15. Avilés, A. and García, R. (1999) "Late evaluation of cardiac toxicity in patients with malignant lymphoma treated with intensive chemotherapy regimens", Cancer Res. Ther. Control, 10, 119-122.
16. Messori, A., Vaini, M., Tripoli, L., et al. (2000) "Survival in patients with intermediate or high-grade non-Hodgkin's lymphoma. Metanalysis of randomized studies comparing third generation with CHOP", Br. J. Cancer, 84, 303-307.
17. Miller, T.P., Dalhberg, S., Cassady, J.R., et al. (1998) "Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high-grade non-Hodgkin's lymphoma", N. Engl. J. Med., 339, 21-26.
18. Kamath, S.S., Marcus, R.B., Lynch, J.W. and Mendelhall, N.P. (1999) "The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma", Int. J. Radiat. Oncol. Biol., 44, 563-568.
19. Rodriguez-Catarino, M., Jerkeman, M., Ahltrom, H., Gimelius, B. and Hagberg, H. (2000) "Residual mass in aggressive lymphoma does size measured computed tomography influence clinical outcome", Acta. Oncol., 39, 485-489.
20. Wilder, R.B., Rodriguez, M.A., Tucker, S.L., et al. (2001) "Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas", Int. J. Radiat. Oncol. Biol. Phys., 50, 743-749.